| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c22f78ac486adee4534dc1c3a59f5de0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196 |
| filingDate |
2016-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14fd39729d4386965d5ac53a48c549e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84d5d6af712f9e670612c97a49c9d339 |
| publicationDate |
2016-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2016171470-A1 |
| titleOfInvention |
Bromodomain-inhibiting compounds and methods to prevent or treat a cancer |
| abstract |
Provided is a novel compound inhibiting the bromodomain and extra terminal domain (BET) proteins, and a pharmaceutical composition comprising the same which can be useful for prevention or treatment of a precancerous transformation or a cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109906220-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112912075-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112912075-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018083051-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7139323-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11021448-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019532989-A |
| priorityDate |
2015-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |